Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
IMI Share News (IMI)
IMI Share
Price
IMI Share
News
IMI Share
Chat
IMI Share
Trades
IMI
Live RNS1
IMI Share
Charts
IMI Level 2
Console
IMI Live
Share Price
IMI Broker
Ratings
IMI Directors
Deals
IMI Financial
Diary
IMI
Fundamentals
IMI Short
Positions
IMI
Media
IMI Company
Research
IMI Company
Timeline1
Share Price Information for IMI (IMI)
Last checked at -
Last checked at 
Intraday IMI Share Chart
Friday broker round-up
IMI: Berenberg initiates at sell with a target price of 875p.
InterContinental Hotels: JP Morgan downgrades to underweight with a target price of 4,700p.
Rio Tinto: JP Morgan reiterates overweight with a target price of 5,500p.
Bovis Homes: Citigroup reiterates neutral with a target price of 1,081p.
Morrisons: Citigroup reiterates neutral with a target price of 205p.
AstraZeneca: Barclays reiterates overweight with a target price of 8,200p.
Petra Diamonds: JP Morgan reiterates neutral with a target price of 25p.
Latest IMI News
- IN BRIEF: IMI says Deutsche to manage GBP250m buyback second tranche
29 May 2026 - DIRECTOR DEALINGS: Clarkson COO sells GBP3.9 million in shares
15 May 2026 - LONDON BROKER RATINGS: RBC cuts Intertek; Jefferies likes IMI
13 May 2026 - LONDON BRIEFING: Babcock launches buyback; Intertek backs EQT bid
13 May 2026 - "Well positioned" IMI backs outlook after first quarter sales growth
12 May 2026 - IMI reaffirms outlook following solid start to the year
12 May 2026 - LONDON BRIEFING: Vodafone profit swings; LondonMetric bids for Picton
12 May 2026 - UK dividends calendar - next 7 days
8 May 2026
Related News
WINNERS & LOSERS: Cizzle secures approval; MediaZest upbeat on outlook
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
EARNINGS AND TRADING: CleanTech loss narrows; Tap Global update
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
AstraZeneca's Ultomiris wins US FDA priority review in kidney disease
(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has accepted and granted priority review to a supplemental biologic...
IMI News
IN BRIEF: IMI says Deutsche to manage GBP250m buyback second tranche
IMI PLC - Birmingham, England-based engineering firm - Announces that, in connection with the share buyback of up to GBP500 million announced in March...
DIRECTOR DEALINGS: Clarkson COO sells GBP3.9 million in shares
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday, Tuesday and Frida...
LONDON BROKER RATINGS: RBC cuts Intertek; Jefferies likes IMI
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:
LONDON BRIEFING: Babcock launches buyback; Intertek backs EQT bid
(Alliance News) - Babcock reports higher annual revenue and launches a GBP200 million share buyback despite a hit from its Type 31 frigate programme, ...
"Well positioned" IMI backs outlook after first quarter sales growth
(Alliance News) - IMI PLC on Tuesday said it is on track to deliver a sixth consecutive year of mid-single-digit organic revenue growth as it reported...
IMI reaffirms outlook following solid start to the year
(Sharecast News) - Fluid and motion control specialist IMI reaffirmed its full-year outlook on Tuesday, despite the outbreak of war in the Middle East...
LONDON BRIEFING: Vodafone profit swings; LondonMetric bids for Picton
(Alliance News) - Vodafone Group swings to an annual profit as impairment charges disappear, while LondonMetric Property agrees a non-binding takeover...
Follow the stocks
